To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers

NCT03543137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DRUG: Nicotine Prototype Mini lozenge
DRUG: Nicorette Mini Lozenge

Sponsor

GlaxoSmithKline